Press

Press Releases
Open letter leads to dialogue The European Patent Office has started a constructive dialogue with patent attorneys and attorneys-at-law on the...
Show release
Press Coverage
Numerous generics manufacturers are now allowed to sell their imitator preparations of the cholesterol-lowering drug Inegy in Germany. The Düsseldorf...
Show release
Press Coverage
The so-called second medical use of medicaments is currently one of the most important topics in European patent law. The Düsseldorf Regional Court...
Show release
Press Coverage
Out of concern for the quality of patent granting by the European Patent Office (EPO), four law firms have addressed an open letter to the current...
Show release
Press Releases
Patent Protection at Risk Open Letter to the European Patent Office: Quality of patent examinations at risk In an open letter to the European Patent...
Show release
Press Coverage
The supplementary protection certificate of the US pharma company Gilead, which covers the active agent combination of the HIV medicament TRUVADA®,...
Show release
Press Coverage
Is it required that an active or an exact active combination is explicitly mentioned in the underlying patent, in order to allow a supplementary...
Show release
Press Releases
Marco Stief, Partner, and Sebastian Haase, Senior Associate, have accompanied the acquisition of Pharmazeutische Fabrik Evers GmbH & Co. KG. The two...
Show release
Press Releases
Extended Patent Protection for Pharmaceutical Companies Prospect of Legal Certainty for all EU Member States Maiwald obtains a referral to the...
Show release
Press Coverage
The law is actually very clear about the circumstances under which applicants may still change the claimed scope of protection of an application in...
Show release

Newsletter